The Current Ratio of Inhibikase Therapeutics Inc (IKT) is 26.37.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-12-31 | 26.37 |
| 2023-12-31 | 4.13 |
| 2022-12-31 | 6.59 |
| 2021-12-31 | 10.49 |
| 2020-12-31 | 3.13 |
| 2019-12-31 | 0.01 |
| 2018-12-31 | 0.35 |
| 2017-12-31 | 0.12 |
| 2016-12-31 | 0.05 |